Bar-Or A - Search Results

1

Bar-Or A. Bar-Or A. Semin Neurol. 2008 Feb;28(1):29-45. doi: 10.1055/s-2007-1019124. Semin Neurol. 2008. PMID: 18256985 Review.

2

Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand.

Kim HJ, Antel JP, Duquette P, Alleva DG, Conlon PJ, Bar-Or A. Kim HJ, et al. Clin Immunol. 2002 Aug;104(2):105-14. doi: 10.1006/clim.2002.5258. Clin Immunol. 2002. PMID: 12165271 Clinical Trial.

3

Do myelin-directed antibodies predict multiple sclerosis?

Antel JP, Bar-Or A. Antel JP, et al. N Engl J Med. 2003 Jul 10;349(2):107-9. doi: 10.1056/NEJMp030098. N Engl J Med. 2003. PMID: 12853581 No abstract available.

4

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, Bourgoin P, Edwards DR, Yong VW. Bar-Or A, et al. Brain. 2003 Dec;126(Pt 12):2738-49. doi: 10.1093/brain/awg285. Epub 2003 Sep 23. Brain. 2003. PMID: 14506071

5

Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients.

Kim HJ, Biernacki K, Prat A, Antel JP, Bar-Or A. Kim HJ, et al. Clin Immunol. 2004 Apr;111(1):38-46. doi: 10.1016/j.clim.2004.01.004. Clin Immunol. 2004. PMID: 15093550

6

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, Jalili F, Bar-Or A. Kim HJ, et al. J Immunol. 2004 Jun 1;172(11):7144-53. doi: 10.4049/jimmunol.172.11.7144. J Immunol. 2004. PMID: 15153538

7

Immunology of multiple sclerosis.

Bar-Or A. Bar-Or A. Neurol Clin. 2005 Feb;23(1):149-75, vii. doi: 10.1016/j.ncl.2004.11.001. Neurol Clin. 2005. PMID: 15661092 Review. No abstract available.

8

Microglia and multiple sclerosis.

Jack C, Ruffini F, Bar-Or A, Antel JP. Jack C, et al. J Neurosci Res. 2005 Aug 1;81(3):363-73. doi: 10.1002/jnr.20482. J Neurosci Res. 2005. PMID: 15948188 Review.

9

Human immune studies in multiple sclerosis.

Bar-Or A. Bar-Or A. Adv Neurol. 2006;98:91-109. Adv Neurol. 2006. PMID: 16400829 Review. No abstract available.

10

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.

O'Connor PW, Li D, Freedman MS, Bar-Or A, Rice GP, Confavreux C, Paty DW, Stewart JA, Scheyer R; Teriflunomide Multiple Sclerosis Trial Group; University of British Columbia MS/MRI Research Group. O'Connor PW, et al. Neurology. 2006 Mar 28;66(6):894-900. doi: 10.1212/01.wnl.0000203121.04509.31. Neurology. 2006. PMID: 16567708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters